Suppr超能文献

[冠状动脉支架。从一个简单想法到一种医学高科技设备]

[Coronary stents. From a simple idea to a medical high-tech device].

作者信息

Wieneke Heinrich, Böse Dirk, Haude Michael, Eggebrecht Holger, Konorza Thomas, Naber Christoph, Erbel Raimund

机构信息

Klinik für Kardiologie, Westdeutsches Herzzentrum, Essen.

出版信息

Med Klin (Munich). 2005 Aug 15;100(8):505-11. doi: 10.1007/s00063-005-1065-6.

Abstract

BACKGROUND

Coronary stents were introduced in clinical cardiology in the middle of the 1980s, as balloon angioplasty was associated with a high incidence of acute vessel closure and restenosis.

EVOLUTION OF CORONARY STENTS

However, primarily designed to counteract elastic recoil after angioplasty, initial results were complicated by acute and subacute stent thrombosis. With the introduction of drugs effectively inhibiting platelet aggregation like ticlopidine and clopidogrel, stent could exhibit its superiority in comparison to angioplasty. Although the incidence of restenosis could be decreased significantly by coronary stents, restenosis remained a major drawback of this interventional technique. Several modifications of stent design and stent material had been tested, but without a real breakthrough. The introduction of active stent coating with anti-inflammatory and antiproliferative drugs marks a milestone in the development of this technology. With this approach the restenosis problem could be, even though not solved, but essentially mitigated. Current developments address bioabsorbable materials to make stents compatible with new upcoming noninvasive imaging techniques.

CONCLUSION

Introduced 20 years ago as a simple wire mesh, modified by new designs and materials, and coated by highly effective drugs, coronary stents have advanced to medical high-tech devices in interventional cardiology.

摘要

背景

冠状动脉支架于20世纪80年代中期被引入临床心脏病学领域,当时球囊血管成形术与急性血管闭塞和再狭窄的高发生率相关。

冠状动脉支架的发展历程

然而,最初设计用于对抗血管成形术后的弹性回缩,但其初期结果因急性和亚急性支架血栓形成而变得复杂。随着噻氯匹定和氯吡格雷等有效抑制血小板聚集的药物的引入,支架相较于血管成形术展现出其优势。尽管冠状动脉支架可显著降低再狭窄的发生率,但再狭窄仍是这项介入技术的主要缺陷。人们对支架设计和支架材料进行了多种改进测试,但均未取得实质性突破。带有抗炎和抗增殖药物的活性支架涂层的引入标志着该技术发展的一个里程碑。通过这种方法,再狭窄问题虽未得到解决,但基本得到了缓解。当前的发展方向是采用可生物吸收材料,以使支架与新出现的无创成像技术兼容。

结论

冠状动脉支架在20年前作为一种简单的金属丝网被引入,经过新的设计和材料改进,并涂覆了高效药物,已发展成为介入心脏病学领域的高科技医疗设备。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验